Ventyx Biosciences Inc. (VTYX)

NASDAQ: VTYX · Real-Time Price · USD

1.38

0.05 (3.76%)

At close: May 01, 2025, 3:59 PM

Ventyx Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	27.26M	61.77M	40.92M	141.9M	51.58M	56.61M	51.72M	63.67M	64.82M	263.27M	45.34M	41.69M	70.79M	68.99M	102.79M	-244K	244K	-309K
Short-Term Investments	190.06M	213.06M	198.51M	160.68M	200.64M	244.21M	280.54M	313.25M	253.12M	149.15M	205.11M	212.66M	187.78M	72.97M	n/a	488K	n/a	618K
Long-Term Investments	35.62M	n/a	41.24M	975K	975K	975K	n/a	n/a	38.67M	n/a	7.9M	18.8M	28.15M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.03M	1.07M	102K	102K	1.08M	102K	102K	96K	96K	72K	72K	60K	60K	2.83M	816K	-244K	n/a	-309K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	-800K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.3M	14.58M	17.49M	n/a	12.13M	7.27M	14.45M	10.14M	12.75M	5.97M	1.74M	3.16M	n/a	782K	n/a	n/a	n/a	n/a
Total Current Assets	229.63M	289.41M	256.93M	319.76M	264.35M	308.09M	346.7M	387.05M	330.69M	418.39M	252.19M	257.5M	263.02M	145.66M	105.03M	244K	245K	309K
Property-Plant & Equipment	10.28M	10.62M	10.92M	11.24M	12.27M	12.53M	1.96M	2.02M	1.94M	1.98M	2.02M	1.59M	254K	219K	72K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	-3.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	46.94M	11.69M	52.26M	12.32M	13.35M	13.61M	2.06M	2.12M	40.71M	2.06M	9.99M	20.45M	28.46M	3.05M	888K	-244K	n/a	-309K
Total Assets	276.56M	301.1M	309.19M	332.08M	277.69M	321.7M	348.76M	389.17M	371.4M	420.44M	262.19M	277.95M	291.48M	148.71M	105.92M	n/a	245K	n/a
Account Payables	3.13M	2.29M	6.58M	5.58M	5.76M	9.34M	4.08M	6.55M	6.43M	18.58M	5.8M	7.11M	4.66M	4.26M	2.37M	n/a	1.1M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-386K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	971K	n/a	n/a	479K	439K	426K	n/a	395K	386K	278K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	6.43M	n/a	n/a	10.64M	11.37M	6.86M	n/a	-395K	-386K	-278K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	12.78M	12.3M	18.1M	14.53M	22.27M	26.21M	20.03M	16.52M	16.36M	35.66M	17.67M	17.79M	12.28M	11.81M	8.06M	n/a	1.4M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.65M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	173.72M	n/a	16.85M	n/a
Total Long-Term Liabilities	9.74M	10.03M	10.29M	10.55M	11.51M	11.85M	922K	1.04M	1.15M	1.25M	1.36M	1.04M	4.66M	224.52M	173.72M	n/a	29.5M	n/a
Total Liabilities	22.52M	22.33M	28.4M	25.08M	33.77M	38.06M	20.96M	17.55M	17.5M	36.91M	19.03M	18.83M	12.28M	236.33M	181.78M	n/a	30.9M	n/a
Total Debt	10.79M	11.04M	11.27M	11.49M	12.51M	12.33M	1.36M	1.46M	1.56M	1.65M	1.75M	1.32M	n/a	224.52M	n/a	n/a	12.65M	n/a
Common Stock	7K	7K	7K	7K	6K	6K	6K	6K	6K	6K	5K	5K	5K	n/a	4K	n/a	n/a	n/a
Retained Earnings	-554.31M	-524.96M	-489.71M	-457.76M	-419.19M	-372.43M	-318.41M	-265.16M	-226.22M	-191.01M	-160.55M	-140.53M	-117.8M	-100.03M	-87.26M	n/a	-32.5M	n/a
Comprehensive Income	157K	873K	-248K	-121K	-50K	-507K	-710K	-561K	-1.12M	-1.31M	-1.29M	-958K	-58K	17K	-12K	-30.65M	n/a	-4.13M
Shareholders Equity	254.04M	278.77M	280.8M	307M	243.92M	283.64M	327.81M	-265.16M	-226.22M	383.53M	243.15M	259.12M	279.2M	-87.62M	-75.86M	-30.65M	-30.65M	-4.13M
Total Investments	225.68M	213.06M	239.75M	161.66M	200.64M	244.21M	280.54M	313.25M	291.79M	149.15M	213.01M	231.46M	215.93M	72.97M	n/a	488K	n/a	618K